Revenue
753 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 753214000 USD Source
Fundies. English
Oaktree Acquisition Corp.
EDGARAnnual consolidated revenue for 2025: about USD 2.348B, using the latest reported figures. The previous period, 2024, was about USD 1.477B.
Latest quarter
Operating margin
-12.9%
2026 Q2 · %
Operating cash flow
-35.9 million USD
2026 Q2 · USD
- Cash and cash equivalents
- 610 million USD Source
Exact value
609811000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 0 shares Source
Exact value
0 shares
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
2.58 billion USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Net income
-142 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
263 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: 238694000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: 89973000 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: 300000000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: 238694000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: 89356000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: 53417000 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: 89356000 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-10.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 7 of 11 periods available· newest 2025-12-31
- Operating income: 7 of 11 periods available· newest 2025-12-31
- Net income: 7 of 11 periods available· newest 2025-12-31
- Operating cash flow: 7 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 7 of 11 periods available· newest 2025-12-31
- Total liabilities: 7 of 11 periods available· newest 2025-12-31
- Current assets: 7 of 11 periods available· newest 2025-12-31
- Current liabilities: 7 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+59%Prior period
USD 1.48 billion
–
Current period
USD 2.35 billion
–
Exact inputs and evidence
2347637000 − 1476514000 = 871123000 USD
1476514000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source2347637000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+1.8%Prior period
USD 126.04 million
–
Current period
USD 128.37 million
–
Exact inputs and evidence
128365000 − 126038000 = 2327000 USD
126038000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source128365000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+19.5%Prior period
USD 251.08 million
–
Current period
USD 300 million
–
Exact inputs and evidence
300000000 − 251084000 = 48916000 USD
251084000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source300000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 2.35 billion 100% of revenue
- Cost of revenue USD 614.26 million 26% of revenue
- Operating expenses USD 1.63 billion 69% of revenue
- Operating income USD 105.61 million 4.5% of revenue
- Tax, interest and other Derived −USD 22.75 million −1% of revenue
- Net income USD 128.37 million 5.5% of revenue
Cash
- Operating cash flow USD 300 million 13% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2019 Operating loss: operating costs were 190% of revenue.
- 2020 Operating loss: operating costs were 110% of revenue.
- 2021 Operating loss: operating costs were 142% of revenue.
- 2022 Operating loss: operating costs were 113% of revenue.
- 2023 Operating loss: operating costs were 103% of revenue.
- 2024 Net income was higher than operating income, so the split is not drawn.
- 2025 Net income was higher than operating income, so the split is not drawn.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2019 2019-01-01 – 2019-12-31 | 82558000 | 156972000 Derived | -74414000 | -2350000 Derived | -72064000 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 148757000 | 163901000 Derived | -15144000 | 2970000 Derived | -18114000 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 271878000 | 386920000 Derived | -115042000 | -7383000 Derived | -107659000 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 526916000 | 595613000 Derived | -68697000 | -3019000 Derived | -65678000 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 872000000 | 901453000 Derived | -29453000 | -5907000 Derived | -23546000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 1476514000 | 1414611000 Derived | 61903000 | -64135000 Derived | 126038000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 2347637000 | 2242024000 Derived | 105613000 | -22752000 Derived | 128365000 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 2.3B 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Revenue | 82558000 |
|
| 2020 | Revenue | 148757000 |
|
| 2021 | Revenue | 271878000 |
|
| 2022 | Revenue | 526916000 |
|
| 2023 | Revenue | 872000000 |
|
| 2024 | Revenue | 1476514000 |
|
| 2025 | Revenue | 2347637000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
59% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | 80.2% |
|
| 2021 | Year over year | 82.8% |
|
| 2022 | Year over year | 93.8% |
|
| 2023 | Year over year | 65.5% |
|
| 2024 | Year over year | 69.3% |
|
| 2025 | Year over year | 59% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 4.5% 2025
Net margin 5.5% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Operating margin | -90.1% |
|
| 2020 | Operating margin | -10.2% |
|
| 2021 | Operating margin | -42.3% |
|
| 2022 | Operating margin | -13% |
|
| 2023 | Operating margin | -3.4% |
|
| 2024 | Operating margin | 4.2% |
|
| 2025 | Operating margin | 4.5% |
|
| 2019 | Net margin | -87.3% |
|
| 2020 | Net margin | -12.2% |
|
| 2021 | Net margin | -39.6% |
|
| 2022 | Net margin | -12.5% |
|
| 2023 | Net margin | -2.7% |
|
| 2024 | Net margin | 8.5% |
|
| 2025 | Net margin | 5.5% |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 300M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Operating cash flow | -74867000 |
|
| 2020 | Operating cash flow | -2479000 |
|
| 2021 | Operating cash flow | -34412000 |
|
| 2022 | Operating cash flow | -26531000 |
|
| 2023 | Operating cash flow | 73483000 |
|
| 2024 | Operating cash flow | 251084000 |
|
| 2025 | Operating cash flow | 300000000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
74.9% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Liabilities / assets | 4% |
|
| 2020 | Liabilities / assets | 13.2% |
|
| 2021 | Liabilities / assets | 20.4% |
|
| 2022 | Liabilities / assets | 14.9% |
|
| 2023 | Liabilities / assets | 22% |
|
| 2024 | Liabilities / assets | 32.6% |
|
| 2025 | Liabilities / assets | 74.9% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
1.9× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Current assets / current liabilities | 1.69× |
|
| 2020 | Current assets / current liabilities | 7.43× |
|
| 2021 | Current assets / current liabilities | 3.41× |
|
| 2022 | Current assets / current liabilities | 4.52× |
|
| 2023 | Current assets / current liabilities | 3× |
|
| 2024 | Current assets / current liabilities | 1.79× |
|
| 2025 | Current assets / current liabilities | 1.9× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2019 2019-01-01 – 2019-12-31 | −USD 72.06 million Exact valueExact value: -72064000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 74.87 million Exact valueExact value: -74867000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 18.11 million Exact valueExact value: -18114000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.48 million Exact valueExact value: -2479000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 107.66 million Exact valueExact value: -107659000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 34.41 million Exact valueExact value: -34412000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 65.68 million Exact valueExact value: -65678000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 26.53 million Exact valueExact value: -26531000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 23.55 million Exact valueExact value: -23546000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 73.48 million Exact valueExact value: 73483000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | USD 126.04 million Exact valueExact value: 126038000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 251.08 million Exact valueExact value: 251084000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | USD 128.37 million Exact valueExact value: 128365000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 300 million Exact valueExact value: 300000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
38 filings · 2,109 latest values · 2,109 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001773751, 1773751, HIMS, edgar:1773751
Also known as HIMS & HERS HEALTH, INC., Hims & Hers Health, Inc., Oaktree Acquisition Corp.